Author

Su‐Kang Shan

Observed names: Su-Kang Shan, Sukang Shan
ORCID: 0000-0003-2907-2190
Observed ORCID: 0000-0003-2907-2190
OpenAlex ID: A5000732161
2023 · Yan-Lin Wu, Zheng-Jun Lin, et al. · Signal Transduction and Targeted Therapy · 477
2019 · Feng Wu, Fuxingzi Li, et al. · Endocrine Related Cancer · 107
2020 · Fu-Xing-Zi Li, Feng Xu, et al. · Frontiers in Endocrinology · 73
2021 · Jia-Yue Duan, Xiao Lin, et al. · Frontiers in Cell and Developmental Biology · 66
2021 · Li-Min Lei, Xiao Lin, et al. · Frontiers in Cell and Developmental Biology · 56
2019 · Su-Kang Shan, Xiao Lin, et al. · Current Pharmaceutical Design · 47
2022 · Xiao Lin, Muhammad Hasnain Ehsan Ullah, et al. · Frontiers in Cardiovascular Medicine · 45
2021 · Yi Wang, Su-Kang Shan, et al. · Frontiers in Endocrinology · 44
2024 · Bei Guo, Tong-Tian Zhuang, et al. · Cardiovascular Diabetology · 34
2023 · Fu-Xing-Zi Li, Jun-Jie Liu, et al. · Journal of Nanobiotechnology · 31
2020 · Yi Wang, Feng Xu, et al. · International Journal of Endocrinology · 28
2022 · Ye-Chi Cao, Su-Kang Shan, et al. · Frontiers in Endocrinology · 25
2022 · Yun-Yun Wu, Su-Kang Shan, et al. · Frontiers in Cardiovascular Medicine · 25
2021 · Wen-Lu Ou-Yang, Bei Guo, et al. · Frontiers in Endocrinology · 23
2023 · Ming-Hui Zheng, Su-Kang Shan, et al. · Journal of Nanobiotechnology · 21
Works count: 45
Citation count: 1,687
H-index: 23
I10-index: 31
Year
Topic
Type